Sign in to confirm you’re not a bot
This helps protect our community. Learn more

Clene Inc., (NASDAQ: CLNN)

Emerging Growth Conference
10.4K subscribers
317 views 1 year ago
Clene Inc., (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. Keynote speaker: Rob Etherington, President / CEO, & Morgan Brown, CFO ...more
...more
Clene Inc., (NASDAQ: CLNN)
9Likes
317Views
2024Jun 12
Clene Inc., (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. Keynote speaker: Rob Etherington, President / CEO, & Morgan Brown, CFO

Follow along using the transcript.

Emerging Growth Conference

10.4K subscribers